We found that plasma ofCS-modified CD44 level was significantly associated with progressive pathologic TNM stage in some cancers, such as breast cancer (BRCA), lung cancer (LC), and liver hepatocellular carcinoma (HCC) (Supplementary Fig. 4a–d), indicating its’ prognostic significance of cancer detection. This evidence concerns the gene CD44 and breast carcinoma.